Jan Chu
Impact in
-
- Innovation and Socioeconomic Development
-
- CAR-T cell therapy research
Papers in
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 1
-
- CRISPR and Genetic Engineering 2
- Co-authors
- Robert Chiesa (3 shared papers)Ajay Vora (3 shared papers)Christos Georgiadis (3 shared papers)Hong Zhan (2 shared papers)Waseem Qasim (3 shared papers)Farhatullah Syed (1 shared paper)Soragia Athina Gkazi (2 shared papers)Giorgio Ottaviano (2 shared papers)
- Partner nations
- United Kingdom
In The Last Decade
Jan Chu
3 papers receiving 203 citations
Jan Chu's Hit Papers
Peers
Comparison fields: 5 of 30
- Business and International Management 11
- Oncology 154
- Genetics 74
- Molecular Biology 120
- Immunology 35
Countries citing papers authored by Jan Chu
This map shows the geographic impact of Jan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Chu more than expected).
Fields of papers citing papers by Jan Chu
This network shows the impact of papers produced by Jan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Chu. The network helps show where Jan Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2023 | 174 |
| 2 | 2022 | 30 | |
| 3 | 2021 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2022 | 0 |
About Jan Chu
Jan Chu is a scholar working on Oncology, Molecular Biology, Genetics, Infectious Diseases and Physiology, having authored 5 papers that have together received 208 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), CRISPR and Genetic Engineering (2 papers), Virus-based gene therapy research (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), COVID-19 Clinical Research Studies (1 paper), Nanowire Synthesis and Applications (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Biomedical Ethics and Regulation (1 paper). The work is most often cited by research in Business and International Management (11 citations), Oncology (154 citations), Genetics (74 citations), Molecular Biology (120 citations) and Immunology (35 citations). Jan Chu has collaborated with scholars based in United Kingdom. Frequent co-authors include Robert Chiesa, Ajay Vora, Christos Georgiadis, Hong Zhan, Waseem Qasim, Farhatullah Syed, Soragia Athina Gkazi, Giorgio Ottaviano, David O’Connor and Stuart Adams. Their work appears in journals such as Blood Advances, New England Journal of Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.